Illumina Inc- 详细介绍、公司背景、业务范围、财务数据以及市场表现

关于 Illumina Inc 公司

Illumina, Inc. 致力于提供基于测序和阵列的遗传和基因组分析解决方案。其产品和服务服务于各个市场的客户，使基因组解决方案能够在研究和临床环境中得到采用。其 DNA 测序技术基于可逆终止子测序化学，称为合成测序生物化学。其 BeadArray 技术在制造过程中结合了微型珠子和基质，以生产可同时执行多项检测的阵列。其测序应用包括全基因组测序试剂盒（可对任何大小和复杂程度的整个基因组进行测序）和靶向重测序试剂盒（可对外显子组、特定基因、RNA 或其他感兴趣的基因组区域进行测序）。其客户包括基因组研究中心、学术机构、政府实验室、医院、制药、生物技术、商业分子诊断实验室等。

Illumina Inc简介



公司代码ILMN

公司名称Illumina Inc

上市日期Jun 28, 2000

CEOMr. Jacob Thaysen, Ph.D.

员工数量8970

证券类型Ordinary Share

年结日Jun 28

公司地址5200 Illumina Way

城市SAN DIEGO

上市交易所NASDAQ Global Select Consolidated

国家United States of America

邮编92122

电话18582024500

网址https://www.illumina.com

公司代码ILMN

上市日期Jun 28, 2000

CEOMr. Jacob Thaysen, Ph.D.

Illumina Inc公司高管



名称

名称/职务

职务

持股

持股变动

Mr. Jacob Thaysen, Ph.D.

Chief Executive Officer, Director

23.64K

-5.22%

Dr. Robert S. (Rob) Epstein, M.D.

Independent Director

22.14K

+20.59%

Dr. Frances H. Arnold, Ph.D.

Independent Director

21.03K

+21.92%

Mr. Philip W. (Phil) Schiller

Independent Director

20.15K

+23.09%

Ms. Patricia (Pat) Leckman

Chief People Officer

19.25K

+60.86%

Mr. Scott Davies

Chief Legal Officer, Secretary

18.93K

+58.70%

Dr. Steven (Steve) Barnard, Ph.D.

Chief Technology Officer

16.84K

-1.68%

Dr. Gary S. Guthart, Ph.D.

Independent Director

16.43K

+29.88%

Ms. Caroline D. Dorsa

Independent Director

15.19K

+21.71%

Ms. Susan E. (Sue) Siegel

Independent Director

14.46K

+35.38%

名称

名称/职务

职务

持股

持股变动

Mr. Jacob Thaysen, Ph.D.

Chief Executive Officer, Director

23.64K

-5.22%

Dr. Robert S. (Rob) Epstein, M.D.

Independent Director

22.14K

+20.59%

Dr. Frances H. Arnold, Ph.D.

Independent Director

21.03K

+21.92%

Mr. Philip W. (Phil) Schiller

Independent Director

20.15K

+23.09%

Ms. Patricia (Pat) Leckman

Chief People Officer

19.25K

+60.86%

Mr. Scott Davies

Chief Legal Officer, Secretary

18.93K

+58.70%

收入明细

单位: USD更新时间: 10月6日周一

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

业务USD

名称

营收

占比

Consumables

811.00M

76.58%

Services and Other revenue

147.00M

13.88%

Instruments

101.00M

9.54%

地区USD

名称

营收

占比

Americas

586.00M

55.34%

Europe

310.00M

29.27%

Asia, Middle East, and Africa

100.00M

9.44%

Greater China

63.00M

5.95%

业务

地区

业务USD

名称

营收

占比

Consumables

811.00M

76.58%

Services and Other revenue

147.00M

13.88%

Instruments

101.00M

9.54%

股东统计

更新时间: 10月7日周二

持股股东

股东类型

持股股东

占比

Capital World Investors

10.83%

The Vanguard Group, Inc.

9.81%

BlackRock Institutional Trust Company, N.A.

8.86%

State Street Investment Management (US)

3.65%

Sessa Capital

3.07%

其他

63.78%

持股股东

占比

Capital World Investors

10.83%

The Vanguard Group, Inc.

9.81%

BlackRock Institutional Trust Company, N.A.

8.86%

State Street Investment Management (US)

3.65%

Sessa Capital

3.07%

其他

63.78%

股东类型

持股股东

占比

Investment Advisor

56.01%

Investment Advisor/Hedge Fund

26.91%

Hedge Fund

13.00%

Pension Fund

3.21%

Bank and Trust

2.05%

Research Firm

1.91%

Family Office

0.39%

Sovereign Wealth Fund

0.23%

Individual Investor

0.19%

机构持股



更新时间: 10月1日周三

报告期

机构数

持股数

持股占比

持股变动

2025Q3

1886

159.00M

103.45%

-23.16M

2025Q2

1978

167.87M

109.04%

-18.11M

2025Q1

2072

170.79M

107.89%

-16.32M

2024Q4

2074

166.23M

104.94%

-15.71M

2024Q3

2038

151.41M

95.06%

-11.30M

2024Q2

2033

149.41M

93.80%

-18.06M

2024Q1

2096

153.02M

96.09%

-8.97M

2023Q4

2134

150.48M

94.76%

-5.28M

2023Q3

2162

152.18M

96.14%

-14.52M

2023Q2

2203

154.10M

97.47%

-5.40M

股东持股明细



名称

持股数

占比

持股变动

变动比例

公告日期

Capital World Investors

16.65M

10.83%

-2.25M

-11.93%

Jun 30, 2025

The Vanguard Group, Inc.

15.08M

9.81%

-1.22M

-7.49%

Jun 30, 2025

BlackRock Institutional Trust Company, N.A.

13.61M

8.86%

-401.16K

-2.86%

Jun 30, 2025

State Street Investment Management (US)

5.62M

3.65%

-234.60K

-4.01%

Jun 30, 2025

Sessa Capital

4.72M

3.07%

+4.72M

--

Jun 30, 2025

WCM Investment Management

4.43M

2.88%

+247.46K

+5.92%

Jun 30, 2025

Loomis, Sayles & Company, L.P.

4.23M

2.75%

+78.32K

+1.89%

Jun 30, 2025

Corvex Management LP

3.83M

2.49%

--

Jun 30, 2025

AQR Capital Management, LLC

3.30M

2.14%

+1.17M

+55.35%

Jun 30, 2025

PointState Capital LP

2.95M

1.92%

+433.53K

+17.23%

Jun 30, 2025

持股ETF



更新时间: 10月6日周一

机构名称

占比

Invesco Biotechnology & Genome ETF

5.73%

Global X Genomics & Biotechnology ETF

4.78%

First Trust Nasdaq Lux Digi Health Solutions ETF

4.48%

ARK Genomic Revolution ETF

3.52%

First Trust NYSE Arca Biotechnology Index Fund

3.27%

VanEck Biotech ETF

2.92%

Alger Russell Innovation ETF

2.12%

Alpha Architect US Quantitative Value ETF

2.03%

First Trust NASDAQ Pharmaceuticals ETF

1.97%

ROBO Global Healthcare Technology & Innovation ETF

1.96%

Invesco Biotechnology & Genome ETF

占比5.73%

Global X Genomics & Biotechnology ETF

占比4.78%

First Trust Nasdaq Lux Digi Health Solutions ETF

占比4.48%

ARK Genomic Revolution ETF

占比3.52%

First Trust NYSE Arca Biotechnology Index Fund

占比3.27%

VanEck Biotech ETF

占比2.92%

Alger Russell Innovation ETF

占比2.12%

Alpha Architect US Quantitative Value ETF

占比2.03%

First Trust NASDAQ Pharmaceuticals ETF

占比1.97%

ROBO Global Healthcare Technology & Innovation ETF

占比1.96%

分红派息



近5年累计派现 0.00 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

暂无数据

拆合股



公告日期

类型

比率

暂无数据

公告日期

类型

比率

暂无数据